Literature DB >> 16955077

Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells.

Yang-ja Lee1, Shin-ichi Miyake, Hideaki Wakita, David C McMullen, Yoshiaki Azuma, Sungyoung Auh, John M Hallenbeck.   

Abstract

Hibernation torpor provides an excellent natural model of tolerance to profound reductions in blood flow to the brain and other organs. Here, we report that during torpor of 13-lined ground squirrels, massive SUMOylation occurs in the brain, liver, and kidney. The level of small ubiquitin-related modifier (SUMO) conjugation coincides with the expression level of Ubc9, the SUMO specific E2-conjugating enzyme. Hypothermia alone also increased SUMO conjugation, but not as markedly as hibernation torpor. Increased SUMO conjugation (induced by Ubc9 overexpression, ischemic preconditioning (PC)+/-hypothermia) was necessary and sufficient for tolerance of SHSY5Y neuroblastoma cells to oxygen/glucose deprivation (OGD) ('in vitro ischemia'); decreased SUMO conjugation (induced by a dominant-negative Ubc9) severely reduced tolerance to OGD in these cells. These data indicate that post-translational modification of proteins by SUMOylation is a prominent feature of hibernation torpor and is critical for cytoprotection by ischemic PC+/-hypothermia in SHSY5Y cells subjected to OGD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955077      PMCID: PMC2396349          DOI: 10.1038/sj.jcbfm.9600395

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

Review 1.  SUMO, ubiquitin's mysterious cousin.

Authors:  S Müller; C Hoege; G Pyrowolakis; S Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 2.  Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases.

Authors:  K L Drew; M E Rice; T B Kuhn; M A Smith
Journal:  Free Radic Biol Med       Date:  2001-09-01       Impact factor: 7.376

Review 3.  SUMO and transcriptional regulation.

Authors:  David W H Girdwood; Michael H Tatham; Ronald T Hay
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

Review 4.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

5.  Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation.

Authors:  K U Frerichs; C B Smith; M Brenner; D J DeGracia; G S Krause; L Marrone; T E Dever; J M Hallenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  RanBP2 associates with Ubc9p and a modified form of RanGAP1.

Authors:  H Saitoh; R Pu; M Cavenagh; M Dasso
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 7.  Cold ischemic organ preservation: lessons from natural systems.

Authors:  Kenneth B Storey
Journal:  J Investig Med       Date:  2004-07       Impact factor: 2.895

8.  Mammalian hibernation: lessons for organ preparation?

Authors:  C Green
Journal:  Cryo Letters       Date:  2000 Mar-Apr       Impact factor: 1.066

9.  Expression level of Ubc9 protein in rat tissues.

Authors:  Filip Gołebiowski; Aneta Szulc; Monika Sakowicz; Andrzej Szutowicz; Tadeusz Pawełczyk
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

10.  Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.

Authors:  T Sternsdorf; K Jensen; H Will
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  83 in total

1.  Insights into cytoprotection from ground squirrel hibernation, a natural model of tolerance to profound brain oligaemia.

Authors:  Y-J Lee; J M Hallenbeck
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

Review 2.  Ubiquitin-proteasome system as a modulator of cell fate.

Authors:  Simon J Thompson; Liam T Loftus; Michelle D Ashley; Robert Meller
Journal:  Curr Opin Pharmacol       Date:  2007-11-05       Impact factor: 5.547

3.  Expression of Nrf2 and its downstream gene targets in hibernating 13-lined ground squirrels, Spermophilus tridecemlineatus.

Authors:  Pier Morin; Zhouli Ni; David C McMullen; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2008-03-10       Impact factor: 3.396

Review 4.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 5.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 6.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury.

Authors:  Keri B Vartanian; Hugh D Mitchell; Susan L Stevens; Valerie K Conrad; Jason E McDermott; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-12       Impact factor: 6.200

Review 8.  The impact of biosampling procedures on molecular data interpretation.

Authors:  Karl Sköld; Henrik Alm; Birger Scholz
Journal:  Mol Cell Proteomics       Date:  2013-02-04       Impact factor: 5.911

9.  Seasonal protein changes support rapid energy production in hibernator brainstem.

Authors:  L Elaine Epperson; James C Rose; Rae L Russell; Mrinalini P Nikrad; Hannah V Carey; Sandra L Martin
Journal:  J Comp Physiol B       Date:  2009-12-05       Impact factor: 2.200

Review 10.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.